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Poor quality medicines (counterfeit/falsified, sub-standard and degraded) constitute a harmful 
threat to the public health, particularly in under-resourced countries [1, 2]. Hence, there is a real 
need to develop fast, efficient, simple and transferable analytical methods applicable for the 
quality control (QC) of medicines in these countries, reinforcing the role of protecting the 
population health. 
In this context, generic and separative methods are required to assess the integrity of drugs. So, a 
robust LC method applicable to 19 antimalarial medicines was developed in Belgium through 
Design of Experiments (DoE) and Design Space (DS) optimization strategies [3]. These 
approaches permitted to gain knowledge on the method, which in turn, were employed to 
develop a procedure meeting specific needs of Rwanda in terms of evaluating the quality of 
antimalarial medicines included in the official document [4]. Thus, this method was specifically 
developed and improved for the analysis of 8 antimalarial Active Pharmaceutical Ingredients 
(APIs) and 4 major excipients. 
Initially developed on a Waters LC system in Belgium, this method was successfully transferred 
to 3 different LC systems in Rwanda namely Shimadzu, Cecil and Agilent, emphasizing the 
interest of robust methods developed through a DoE-DS strategy. Rapid, reliable and 
reproducible chromatographic results were obtained with these LC systems, with respect to 
peaks retention times. In order to give more guarantees to the Rwandan health authorities as well 
as other health organizations, further transfers, i.e. geometric ones were realized taking into 
account several combinations of antimalarial medicines as well as the pharmaceutical 
formulations. Prior to their use to QC of medicines sampled in specific and targeted areas of 
Rwanda, the methods were validated using the total error strategy [5]. Very interesting and 
surprising results were obtained in terms of falsification detection particularly in the Rwandan 
fragile areas such as boundaries. 
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